☰

Madhuri Wadehra, Ph.D. - Publications

Affiliations: 
2002 University of California, Los Angeles, Los Angeles, CA 
Area:
Oncology, Molecular Biology, Cell Biology
Tree Info Similar researchers PubMed Report error

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Chan AM, Olafsen T, Tsui J, Salazar FB, Aguirre B, Zettlitz KA, Condro M, Wu AM, Braun J, Gordon LK, Ashki N, Whitelegge J, Xu S, Ikotun O, Lee JT, ... Wadehra M, et al. 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular Cancer Therapeutics. PMID 38417138 DOI: 10.1158/1535-7163.MCT-23-0465  0.489
2022 Mozaffari K, Mekonnen M, Harary M, Lum M, Aguirre B, Chandla A, Wadehra M, Yang I. Epithelial membrane protein 2 (EMP2): A systematic review of its implications in pathogenesis. Acta Histochemica. 125: 151976. PMID 36455339 DOI: 10.1016/j.acthis.2022.151976  0.342
2022 Sun M, Cherian N, Liu L, Chan AM, Aguirre B, Chu A, Strawbridge J, Kim ES, Lin MC, Tsui I, Gordon LK, Wadehra M. Epithelial membrane protein 2 (EMP2) regulates hypoxia-induced angiogenesis in the adult retinal pigment epithelial cell lines. Scientific Reports. 12: 19432. PMID 36371458 DOI: 10.1038/s41598-022-22696-x  0.424
2020 Patel KS, Kejriwal S, Thammachantha S, Duong C, Murillo A, Gordon LK, Cloughesy TF, Liau L, Yong W, Yang I, Wadehra M. Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab. Neuro-Oncology Advances. 2: vdaa112. PMID 33063013 DOI: 10.1093/noajnl/vdaa112  0.434
2020 Dillard CM, Kiyohara M, Mah V, McDermott SP, Bazzoun D, Tsui J, Chan AM, Haddad G, Pellegrini M, Chang YL, Elshimali Y, Wu Y, Vadgama JV, Kim SR, Goodglick L, ... ... Wadehra M, et al. EMP2 is a novel regulator of stemness in breast cancer cells. Molecular Cancer Therapeutics. PMID 32451329 DOI: 10.1158/1535-7163.Mct-19-0850  0.603
2020 Sun M, Wadehra M, Casero D, Lin MC, Aguirre B, Parikh S, Matynia A, Gordon L, Chu A. Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy. Investigative Ophthalmology & Visual Science. 61: 3. PMID 32031575 DOI: 10.1167/Iovs.61.2.3  0.421
2020 Patel KS, Kejriwal S, Sun MM, Thammachantha S, Duong C, Chan A, Cherian N, Romiyo P, Gordon LK, Yong W, Wadehra M, Yang I. Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma. Journal of Neuro-Oncology. PMID 31981014 DOI: 10.1007/S11060-020-03401-2  0.339
2020 Mohamedali KA, Su-yin K, Cheung LH, Dhawan N, Rosenblum MG, Wadehra M. Abstract 2891: Targeting breast cancer stem cells with anti-EMP2 immunotoxins delivering granzyme b Cancer Research. 80: 2891-2891. DOI: 10.1158/1538-7445.Am2020-2891  0.486
2019 Zhao Y, Kang X, Gao F, Guzman A, Lau RP, Biniwale R, Wadehra M, Reemtsen B, Garg M, Halnon N, Quintero-Rivera F, Van Arsdell G, Coppola G, Nelson SF, Touma M, et al. Gene-environment regulatory circuits of right ventricular pathology in tetralogy of fallot. Journal of Molecular Medicine (Berlin, Germany). PMID 31834445 DOI: 10.1007/S00109-019-01857-Y  0.32
2019 Chu A, Najafzadeh P, Sullivan P, Cone B, Elshimali R, Shakeri H, Janzen C, Mah V, Wadehra M. Aldehyde dehydrogenase isoforms and inflammatory cell populations are differentially expressed in term human placentas affected by intrauterine growth restriction. Placenta. 81: 9-17. PMID 31138432 DOI: 10.1016/J.Placenta.2019.03.015  0.303
2019 Sun MM, Chan AM, Law SM, Duarte S, Diaz-Aguilar D, Wadehra M, Gordon LK. Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model. Investigative Ophthalmology & Visual Science. 60: 245-254. PMID 30646013 DOI: 10.1167/Iovs.18-24345  0.437
2019 Mohamedali K, Kok S, Cheung LH, Rosenblum MG, Wadehra M. Abstract 1218: EMP2 serves as a novel target for immunotoxin mediated ovarian cancer therapy Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1218  0.305
2019 Patel K, Duong C, Sun M, Romiyo P, Kejriwal S, Chan A, Gordon L, Wadehra M, Yang I. GENE-53. IDENTIFICATION OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) AS A MOLECULAR MARKER AND THERAPEUTIC TARGET IN MENINGIOMA Neuro-Oncology. 21: vi109-vi109. DOI: 10.1093/Neuonc/Noz175.455  0.431
2018 Mohamedali K, Mohandessi S, Cheung L, Rosenblum MG, Wadehra M. Abstract 4937: Targeting epithelial membrane protein 2 on breast tumor cells with a fusion construct containing the serine protease granzyme B Immunology. DOI: 10.1158/1538-7445.Am2018-4937  0.425
2017 Chung LK, Pelargos PE, Chan AM, Demos JV, Lagman C, Sheppard JP, Nguyen T, Chang YL, Hojat SA, Prins RM, Liau LM, Nghiemphu L, Lai A, Cloughesy TF, Yong WH, ... ... Wadehra M, et al. Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas. Brain Tumor Pathology. PMID 28887715 DOI: 10.1007/S10014-017-0300-1  0.432
2017 Chung LK, Bhatt NS, Lagman C, Pelargos PE, Qin Y, Gordon LK, Wadehra M, Yang I. Epithelial membrane protein 2: Molecular interactions and clinical implications. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 28720310 DOI: 10.1016/J.Jocn.2017.06.044  0.433
2017 Kiyohara MH, Dillard C, Tsui J, Kim SR, Lu J, Sachdev D, Goodglick L, Tong M, Torous VF, Aryasomayajula C, Wang W, Najafzadeh P, Gordon LK, Braun J, McDermott S, ... ... Wadehra M, et al. EMP2 is a novel therapeutic target for endometrial cancer stem cells. Oncogene. PMID 28604744 DOI: 10.1038/Onc.2017.142  0.737
2017 Qin Y, Takahashi M, Sheets K, Soto H, Tsui J, Pelargos P, Antonios JP, Kasahara N, Yang I, Prins RM, Braun J, Gordon LK, Wadehra M. Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme. Journal of Neuro-Oncology. PMID 28597184 DOI: 10.1007/S11060-017-2507-8  0.58
2017 Williams CJ, Chu A, Jefferson WN, Casero D, Sudhakar D, Khurana N, Hogue CP, Aryasomayajula C, Patel P, Sullivan P, Padilla-Banks E, Mohandessi S, Janzen C, Wadehra M. Epithelial membrane protein 2 (EMP2) deficiency alters placental angiogenesis, mimicking features of human placental insufficiency. The Journal of Pathology. PMID 28295343 DOI: 10.1002/Path.4893  0.506
2017 Mohandessi S, Dunnsiri T, Aryasomayajula C, Wadehra M. Abstract B40: Anti-EMP2 IgG Mono Methyl Auristatin E (MMAE) antibody-drug conjugate (ADC) as a potential cancer therapeutic Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Pmccavuln16-B40  0.407
2017 Tsui J, Ashki N, Chang Y, Patel D, Sjarif J, Wadehra M. Abstract 3965: Epithelial membrane protein-2 is a novel regulator of immune editing in breast cancer Cancer Research. 77: 3965-3965. DOI: 10.1158/1538-7445.Am2017-3965  0.476
2016 Chu A, Thamotharan S, Ganguly A, Wadehra M, Pellegrini M, Devaskar SU. Gestational food restriction decreases placental interleukin-10 expression and markers of autophagy and endoplasmic reticulum stress in murine intrauterine growth restriction. Nutrition Research (New York, N.Y.). 36: 1055-1067. PMID 27865347 DOI: 10.1016/J.Nutres.2016.08.001  0.339
2016 Bentolila LA, Prakash R, Mihic-Probst D, Wadehra M, Kleinman HK, Carmichael TS, Péault B, Barnhill RL, Lugassy C. Imaging of Angiotropism/Vascular Co-Option in a Murine Model of Brain Melanoma: Implications for Melanoma Progression along Extravascular Pathways. Scientific Reports. 6: 23834. PMID 27048955 DOI: 10.1038/Srep23834  0.398
2016 Ashki N, Tsui J, Wadehra M. Abstract 1478: Anti-EMP2 IgG1 combined with anti-PD1/PDL1 antibodies synergistically reduce tumor load in animal models of breast cancer Cancer Research. 76: 1478-1478. DOI: 10.1158/1538-7445.Am2016-1478  0.413
2015 Ashki N, Gordon L, Wadehra M. Review of the GAS3 Family of Proteins and their Relevance to Cancer. Critical Reviews in Oncogenesis. 20: 435-47. PMID 27279240 DOI: 10.1615/Critrevoncog.V20.I5-6.140  0.322
2015 Qin Y, Mohandessi S, Gordon L, Wadehra M. Regulation of FAK Activity by Tetraspan Proteins: Potential Clinical Implications in Cancer. Critical Reviews in Oncogenesis. 20: 391-405. PMID 27279237 DOI: 10.1615/Critrevoncog.V20.I5-6.110  0.45
2015 Qin Y, Mohandessi S, Gordon L, Wadehra M. Regulation of FAK activity by tetraspan proteins: Potential clinical implications in cancer Critical Reviews in Oncogenesis. 20: 391-406. DOI: 10.1615/CritRevOncog.v20.i5-6.110  0.344
2015 Pelargos P, Qin Y, Voth B, Thill K, Chung L, Prins R, Liau L, Ung N, Hojat S, Yong W, Gordon L, Wadehra M, Yang I. MPTH-27A LARGE-SCALE UCLA GLIOMA TISSUE MICROARRAY IDENTIFIES EMP2 AS A NOVEL BIOMARKER FOR GBM THAT CORRELATES WITH OVERALL PROGNOSIS Neuro-Oncology. 17: v144.2-v144. DOI: 10.1093/Neuonc/Nov222.27  0.478
2015 Pelargos P, Qin Y, Voth B, Thill K, Chung L, Prins R, Liau L, Ung N, Hojat S, Yong W, Gordon L, Wadehra M, Yang I. ATPS-62TARGETING OF NOVEL GBM BIOMARKER EMP2 RESULTS IN DECREASED TUMOR GROWTH AND INCREASED TUMOR NECROSIS Neuro-Oncology. 17: v31.5-v32. DOI: 10.1093/Neuonc/Nov204.62  0.433
2014 Lugassy C, Zadran S, Bentolila LA, Wadehra M, Prakash R, Carmichael ST, Kleinman HK, Péault B, Larue L, Barnhill RL. Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: an alternative to intravascular cancer dissemination. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 7: 139-52. PMID 25304454 DOI: 10.1007/S12307-014-0156-4  0.449
2014 Qin Y, Fu M, Takahashi M, Iwanami A, Kuga D, Rao RG, Sudhakar D, Huang T, Kiyohara M, Torres K, Dillard C, Inagaki A, Kasahara N, Goodglick L, Braun J, ... ... Wadehra M, et al. Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma. The Journal of Biological Chemistry. 289: 13974-85. PMID 24644285 DOI: 10.1074/Jbc.M113.543728  0.748
2014 Fu M, Maresh EL, Helguera GF, Kiyohara M, Qin Y, Ashki N, Daniels-Wells TR, Aziz N, Gordon LK, Braun J, Elshimali Y, Soslow RA, Penichet ML, Goodglick L, Wadehra M. Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer. Molecular Cancer Therapeutics. 13: 902-15. PMID 24448822 DOI: 10.1158/1535-7163.Mct-13-0199  0.587
2014 Ashki N, Chan AM, Qin Y, Wang W, Kiyohara M, Lin L, Braun J, Wadehra M, Gordon LK. Peroxynitrite upregulates angiogenic factors VEGF-A, BFGF, and HIF-1α in human corneal limbal epithelial cells. Investigative Ophthalmology & Visual Science. 55: 1637-46. PMID 24398102 DOI: 10.1167/Iovs.13-12410  0.565
2014 Wadehra M, Kiyohara M. Abstract 665: Therapeutic targeting of breast cancer stem cells using PG-101 improves breast cancer survival Cancer Research. 74: 665-665. DOI: 10.1158/1538-7445.Am2014-665  0.422
2013 Lugassy C, Péault B, Wadehra M, Kleinman HK, Barnhill RL. Could pericytic mimicry represent another type of melanoma cell plasticity with embryonic properties? Pigment Cell & Melanoma Research. 26: 746-54. PMID 23789776 DOI: 10.1111/Pcmr.12120  0.413
2013 Morales SA, Telander DG, Leon D, Forward K, Braun J, Wadehra M, Gordon LK. Epithelial membrane protein 2 controls VEGF expression in ARPE-19 cells. Investigative Ophthalmology & Visual Science. 54: 2367-72. PMID 23439602 DOI: 10.1167/Iovs.12-11013  0.8
2013 Gordon LK, Kiyohara M, Fu M, Braun J, Dhawan P, Chan A, Goodglick L, Wadehra M. EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF. Oncogene. 32: 5369-76. PMID 23334331 DOI: 10.1038/Onc.2012.622  0.61
2013 Lugassy C, Wadehra M, Li X, Corselli M, Akhavan D, Binder SW, Péault B, Cochran AJ, Mischel PS, Kleinman HK, Barnhill RL. Pilot study on "pericytic mimicry" and potential embryonic/stem cell properties of angiotropic melanoma cells interacting with the abluminal vascular surface. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 6: 19-29. PMID 23275074 DOI: 10.1007/S12307-012-0128-5  0.457
2013 Fu M, Brewer S, Olafsen T, Wu AM, Gordon LK, Said J, Braun J, Wadehra M. Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 68-78. PMID 22585360 DOI: 10.1007/S11307-012-0558-Y  0.569
2013 Wadehra M, Kiyohara M, Ashki N, Chan A. Effect of therapeutic targeting of EMP2 on breast and endometrial cancer stem cells. Journal of Clinical Oncology. 31: 3080-3080. DOI: 10.1200/Jco.2013.31.15_Suppl.3080  0.465
2013 Wadehra M, Kiyohara M, Ashki N. Abstract 240: Therapeutic targeting of EMP2 reduces breast cancer stem cells. Cancer Research. 73: 240-240. DOI: 10.1158/1538-7445.Am2013-240  0.32
2012 Morales SA, Telander DG, Mareninov S, Nagy A, Wadehra M, Braun J, Gordon LK. Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells. Experimental Eye Research. 102: 10-6. PMID 22728127 DOI: 10.1016/J.Exer.2012.06.002  0.8
2012 Sullivan PS, Maresh EL, Seligson DB, Habeeb O, Wadehra M, Goodglick L, Dorigo O. Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 25: 1140-8. PMID 22460811 DOI: 10.1038/Modpathol.2012.64  0.393
2012 Wadehra M, Kiyohara M, Fu M, Gordon LK, Braun J. Effect of therapeutic targeting of the oncogene EMP2 in triple-negative breast cancer on tumor load. Journal of Clinical Oncology. 30: 1052-1052. DOI: 10.1200/Jco.2012.30.15_Suppl.1052  0.607
2012 Goodglick L, Fu M, Braun J, Wadehra M. Abstract 4621: EMP2 regulates the tumor microenvironment and is a novel therapeutic target for triple negative breast cancer Cancer Research. 72: 4621-4621. DOI: 10.1158/1538-7445.Am2012-4621  0.615
2011 Fu M, Rao R, Sudhakar D, Hogue CP, Rutta Z, Morales S, Gordon LK, Braun J, Goodglick L, Wadehra M. Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src. Plos One. 6: e19945. PMID 21637765 DOI: 10.1371/Journal.Pone.0019945  0.815
2011 Rao RG, Sudhakar D, Hogue CP, Amici S, Gordon LK, Braun J, Notterpek L, Goodglick L, Wadehra M. Peripheral myelin protein-22 (PMP22) modulates alpha 6 integrin expression in the human endometrium. Reproductive Biology and Endocrinology : Rb&E. 9: 56. PMID 21518455 DOI: 10.1186/1477-7827-9-56  0.637
2011 Morales SA, Telander D, Notterpek L, Wadehra M, Braun J, Gordon LK. Rewiring integrin-mediated signaling and cellular response with the peripheral myelin protein 22 and epithelial membrane protein 2 components of the tetraspan web. Investigative Ophthalmology & Visual Science. 52: 5465-72. PMID 21421883 DOI: 10.1167/Iovs.10-6139  0.818
2011 Fu M, Brewer S, Braun J, Wadehra M. Abstract 5310: Positron emission tomography imaging of endometrial cancer using an anti-EMP2 minibody Cancer Research. 71: 5310-5310. DOI: 10.1158/1538-7445.Am2011-5310  0.594
2011 Fu M, Goodglick L, Gordon LK, Braun J, Wadehra M. Abstract 3624: Therapeutic targeting of glioblastoma multiforme using anti-EMP2 antibodies Cancer Research. 71: 3624-3624. DOI: 10.1158/1538-7445.Am2011-3624  0.665
2010 Fu M, Maresh EL, Soslow RA, Alavi M, Mah V, Zhou Q, Iasonos A, Goodglick L, Gordon LK, Braun J, Wadehra M. Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3954-63. PMID 20670949 DOI: 10.1158/1078-0432.Ccr-10-0368  0.637
2010 Habeeb O, Goodglick L, Soslow RA, Rao RG, Gordon LK, Schirripa O, Horvath S, Braun J, Seligson DB, Wadehra M. Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development. Cancer. 116: 4718-26. PMID 20578181 DOI: 10.1002/Cncr.25259  0.6
2009 Morales SA, Mareninov S, Coulam P, Wadehra M, Goodglick L, Braun J, Gordon LK. Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2). Investigative Ophthalmology & Visual Science. 50: 4949-56. PMID 19494199 DOI: 10.1167/Iovs.08-3315  0.804
2009 Shimazaki K, Chan AM, Moniz RJ, Wadehra M, Nagy A, Coulam CP, Mareninov S, Lepin EM, Wu AM, Kelly KA, Braun J, Gordon LK. Blockade of epithelial membrane protein 2 (EMP2) abrogates infection of Chlamydia muridarum murine genital infection model. Fems Immunology and Medical Microbiology. 55: 240-9. PMID 19159428 DOI: 10.1111/J.1574-695X.2008.00525.X  0.649
2009 Morales SA, Mareninov S, Wadehra M, Zhang L, Goodglick L, Braun J, Gordon LK. FAK activation and the role of epithelial membrane protein 2 (EMP2) in collagen gel contraction. Investigative Ophthalmology & Visual Science. 50: 462-9. PMID 18469192 DOI: 10.1167/Iovs.07-1598  0.816
2009 Brewer S, Fu M, Gordon L, Braun J, Wadehra M. S.36. Therapeutic Targeting and Imaging of EMP2 in Endometrial Cancer Clinical Immunology. 131: S143. DOI: 10.1016/J.Clim.2009.03.420  0.467
2008 Shimazaki K, Lepin EJ, Wei B, Nagy AK, Coulam CP, Mareninov S, Fu M, Wu AM, Marks JD, Braun J, Gordon LK, Wadehra M. Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7367-77. PMID 19010852 DOI: 10.1158/1078-0432.Ccr-08-1016  0.742
2008 Wadehra M, Mainigi M, Morales SA, Rao RG, Gordon LK, Williams CJ, Braun J. Steroid hormone regulation of EMP2 expression and localization in the endometrium. Reproductive Biology and Endocrinology : Rb&E. 6: 15. PMID 18400107 DOI: 10.1186/1477-7827-6-15  0.804
2007 Morales SA, Mareninov S, Prasad P, Wadehra M, Braun J, Gordon LK. Collagen gel contraction by ARPE-19 cells is mediated by a FAK-Src dependent pathway. Experimental Eye Research. 85: 790-8. PMID 17915217 DOI: 10.1016/J.Exer.2007.08.014  0.789
2007 Forbes A, Wadehra M, Mareninov S, Morales S, Shimazaki K, Gordon LK, Braun J. The tetraspan protein EMP2 regulates expression of caveolin-1. The Journal of Biological Chemistry. 282: 26542-51. PMID 17609206 DOI: 10.1074/Jbc.M702117200  0.778
2007 Shimazaki K, Wadehra M, Forbes A, Chan AM, Goodglick L, Kelly KA, Braun J, Gordon LK. Epithelial membrane protein 2 modulates infectivity of Chlamydia muridarum (MoPn). Microbes and Infection / Institut Pasteur. 9: 1003-10. PMID 17544801 DOI: 10.1016/J.Micinf.2007.04.004  0.782
2006 Wadehra M, Natarajan S, Seligson DB, Williams CJ, Hummer AJ, Hedvat C, Braun J, Soslow RA. Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome. Cancer. 107: 90-8. PMID 16736513 DOI: 10.1002/Cncr.21957  0.609
2006 Wadehra M, Dayal M, Mainigi M, Ord T, Iyer R, Braun J, Williams CJ. Knockdown of the tetraspan protein epithelial membrane protein-2 inhibits implantation in the mouse. Developmental Biology. 292: 430-41. PMID 16487956 DOI: 10.1016/J.Ydbio.2006.01.015  0.584
2005 Wadehra M, Forbes A, Pushkarna N, Goodglick L, Gordon LK, Williams CJ, Braun J. Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium. Developmental Biology. 287: 336-45. PMID 16216233 DOI: 10.1016/J.Ydbio.2005.09.003  0.801
2004 Dahlin K, Mager EM, Allen L, Tigue Z, Goodglick L, Wadehra M, Dobbs L. Identification of genes differentially expressed in rat alveolar type I cells. American Journal of Respiratory Cell and Molecular Biology. 31: 309-16. PMID 15205179 DOI: 10.1165/Rcmb.2003-0423Oc  0.396
2004 Wadehra M, Goodglick L, Braun J. The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins. Molecular Biology of the Cell. 15: 2073-83. PMID 14978215 DOI: 10.1091/Mbc.E03-07-0488  0.597
2004 Modjtahedi S, Ziv N, Sulur G, Wadehra M, Goodglick L. 31 EXPRESSION PATTERN OF EPITHELIAL MEMBRANE PROTEIN 2 IN NORMAL AND MALIGNANT SKIN AND LUNG Journal of Investigative Medicine. 52: S84.1-S84. DOI: 10.1136/Jim-52-Suppl1-31  0.397
2003 Wadehra M, Su H, Gordon LK, Goodglick L, Braun J. The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death. Clinical Immunology (Orlando, Fla.). 107: 129-36. PMID 12763482 DOI: 10.1016/S1521-6616(03)00048-2  0.661
2003 Wadehra M, Sulur GG, Braun J, Gordon LK, Goodglick L. Epithelial membrane protein-2 is expressed in discrete anatomical regions of the eye. Experimental and Molecular Pathology. 74: 106-12. PMID 12710941 DOI: 10.1016/S0014-4800(03)00009-1  0.567
2002 Wadehra M, Iyer R, Goodglick L, Braun J. The tetraspan protein epithelial membrane protein-2 interacts with beta1 integrins and regulates adhesion. The Journal of Biological Chemistry. 277: 41094-100. PMID 12189152 DOI: 10.1074/Jbc.M206868200  0.573
2002 Wadehra M, Braun J, Goodglick L. One-step RT-PCR for screening microdissected tissue samples. Biotechniques. 32: 242, 244, 246, 248. PMID 11848395 DOI: 10.2144/02322Bm02  0.418
2002 Dayal MB, Wadehra M, Ord T, Braun J, Williams CJ. Inhibition of EMP2 expression prevents mouse blastocyst attachment in vitro and implantation in vivo Fertility and Sterility. 78: S4. DOI: 10.1016/S0015-0282(02)03388-5  0.517
2001 Wang CX, Wadehra M, Fisk BC, Goodglick L, Braun J. Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity. Blood. 97: 3890-5. PMID 11389031 DOI: 10.1182/Blood.V97.12.3890  0.627
2000 Wang CX, Fisk BC, Wadehra M, Su H, Braun J. Overexpression of murine fizzy-related (fzr) increases natural killer cell-mediated cell death and suppresses tumor growth. Blood. 96: 259-63. PMID 10891459 DOI: 10.1182/Blood.V96.1.259.013K36_259_263  0.599
Show low-probability matches.